SCHEMBL3353073

SCHEMBL3353073

CC(=O)CCc1ccsc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
TAAR1 Q96RJ0 1/20 0.50
DRD2 P14416 1/20 0.46
DRD3 P35462 1/20 0.46
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
MAPT P10636 2/20 0.42
MEN1 O00255 1/20 0.42
KDM4A O75164 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42
KDM4C Q9H3R0 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
OPRM1 P35372 2/20 0.42
OPRD1 P41143 2/20 0.42
NAAA Q02083 1/20 0.41
CYP1A2 P05177 2/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3346301 0.89 TAAR1 (0.47) ALDH1A1TAAR1DRD2DRD3NPC1
SCHEMBL7331954 0.83 TAAR1 (0.54) ALDH1A1TAAR1DRD2DRD3NPC1
SCHEMBL27326357 0.83 TAAR1 (0.54) ALDH1A1TAAR1DRD2DRD3NPC1
SCHEMBL599876 0.82 KEAP1 (0.54) TAAR1DRD2DRD3OPRM1OPRD1
SCHEMBL12530212 0.81 IAPP (0.50) ALDH1A1TAAR1DRD2DRD3NPC1
SCHEMBL4461408 0.81 OPRM1 (0.49) ALDH1A1TAAR1DRD2DRD3NPC1
SCHEMBL8352443 0.80 TAAR1 (0.50) ALDH1A1TAAR1DRD2DRD3NPC1
SCHEMBL2102408 0.80 TAAR1 (0.55) ALDH1A1TAAR1DRD2DRD3MAPT
Hydrochloric Acid SCHEMBL27428710 0.80 KEAP1 (0.52) TAAR1DRD2DRD3OPRM1OPRD1
SCHEMBL6296479 0.79 TAAR1 (0.46) ALDH1A1TAAR1DRD2DRD3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010053388-A1 NEW 4,6-DISUBSTITUTED 2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS, THEIR USE, A METHOD FOR MODULATING MONOAMINERGIC RECEPTOR ACTIVITY AND A MONOAMINERGIC RECEPTOR MODULATING AGENT INSTYTUT FARMAKOLOGII POLSKIEJ AKADEMII NAUK (PL) 2010-05-14 WO disclosed
EP-1725540-A1 DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2006-11-29 EP disclosed
WO-2005095359-A1 DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2005-10-13 WO disclosed